An HPV vaccine delivered into the nose can treat cervical tumors in mice. The vaccine targets a cancer protein produced by the virus.

Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW ...

Over the long term, cervical cancer risk after HPV vaccination fell 63% (RR 0.37, 95% CI 0.25-0.56) based on adjusted ...

Two new reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and ...

Cervical cancer is the fourth most common cancer in women worldwide and causes more than 300,000 deaths each year ...

HPV vaccines are proving highly effective in preventing cervical cancer and precancerous lesions. Studies show significant ...

New stats show 90.7% of pupils in the least deprived areas had the vaccine but that dropped to 74.6% in the poorest areas.

HPV vaccination reduces the incidence of cervical cancer by about 80 per cent in people vaccinated at or before the age of 16 ...

Pregnant women who were vaccinated against human papillomavirus (HPV) at school are less likely to experience serious ...

HPV vaccines aim to prevent the types of HPV infections that sometimes cause cancers and anogenital warts. The HPV vaccines do not work as well in people that have already been exposed to HPV, so most ...

"Together Against HPV" is an awareness initiative focused on preventing cervical cancer through education, vaccination, and ...

Oral cancer is considered one of the less-discussed malignancies, even though its incidence continues to rise steadily in ...